Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth
- PMID: 10806305
- DOI: 10.1016/s0304-3835(00)00392-x
Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth
Abstract
We attempted to suppress glucose transporter 1 (GLUT1) expression by transfecting MKN45 cells with cDNA for antisense GLUT1. Glucose transport was significantly decreased in cells with antisense GLUT1 compared with wild-type cells or cells with vector alone. Suppression of GLUT1 mRNA resulted in a decreased number of cells in the S phase. This was accompanied by overexpression of p21 protein. Tumorigenicity in the nude mice injected with antisense GLUT1 expressing cells was significantly slower than in those with wild-type MKN45 cells. These results suggest that antisense GLUT1 mRNA inhibits tumor growth through a G(1) arrest and that expression of antisense GLUT1 mRNA via gene therapy can be used as a tool in the treatment of cancer.
Similar articles
-
Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.Cancer Lett. 2000 Jun 30;154(2):137-42. doi: 10.1016/s0304-3835(00)00354-2. Cancer Lett. 2000. PMID: 10806301
-
Antisense GLUT1 RNA suppresses the transforming phenotypes of NIH 3T3 cells transformed by N-Ras.Yonsei Med J. 1995 Dec;36(6):480-6. doi: 10.3349/ymj.1995.36.6.480. Yonsei Med J. 1995. PMID: 8599249
-
Human rhabdomyosarcoma cells retain insulin-regulated glucose transport activity through glucose transporter 1.Arch Biochem Biophys. 2000 Jan 1;373(1):72-82. doi: 10.1006/abbi.1999.1535. Arch Biochem Biophys. 2000. PMID: 10620325
-
High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo.J Endocrinol. 1999 Mar;160(3):443-52. doi: 10.1677/joe.0.1600443. J Endocrinol. 1999. PMID: 10076190
-
Oligonucleotide treatment of ras-induced tumors in nude mice.Mol Biotechnol. 2001 May;18(1):35-55. doi: 10.1385/MB:18:1:35. Mol Biotechnol. 2001. PMID: 11439698 Review.
Cited by
-
Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth.BMC Bioinformatics. 2012;13 Suppl 14(Suppl 14):S14. doi: 10.1186/1471-2105-13-S14-S14. Epub 2012 Sep 7. BMC Bioinformatics. 2012. PMID: 23095709 Free PMC article.
-
Obesity and Energy Substrate Transporters in Ovarian Cancer-Review.Molecules. 2021 Mar 16;26(6):1659. doi: 10.3390/molecules26061659. Molecules. 2021. PMID: 33809784 Free PMC article. Review.
-
Current gene therapy for stomach carcinoma.World J Gastroenterol. 2001 Dec;7(6):752-9. doi: 10.3748/wjg.v7.i6.752. World J Gastroenterol. 2001. PMID: 11819868 Free PMC article. Review. No abstract available.
-
The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.Oncotarget. 2017 Jun 27;8(26):43356-43367. doi: 10.18632/oncotarget.17445. Oncotarget. 2017. PMID: 28498810 Free PMC article. Review.
-
Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma.Int J Med Sci. 2013 Aug 21;10(10):1375-86. doi: 10.7150/ijms.6855. eCollection 2013. Int J Med Sci. 2013. PMID: 23983599 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous